Healthcare - Medical - Diagnostics & Research - NASDAQ - DE
$ 0.2387
-4.52 %
$ 5.22 M
Market Cap
-0.22
P/E
BALANCE SHEET
15.4 M
ASSETS
12.2 M
LIABILITIES
3.25 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Mainz Biomed B.V.
| Current Assets | 8.98 M |
| Cash & Short-Term Investments | 7.07 M |
| Receivables | 355 K |
| Other Current Assets | 1.55 M |
| Non-Current Assets | 6.43 M |
| Long-Term Investments | 0 |
| PP&E | 3.03 M |
| Other Non-Current Assets | 3.39 M |
| Current Liabilities | 9.24 M |
| Accounts Payable | 2.33 M |
| Short-Term Debt | 5.22 M |
| Other Current Liabilities | 1.69 M |
| Non-Current Liabilities | 2.92 M |
| Long-Term Debt | 2.2 M |
| Other Non-Current Liabilities | 727 K |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 7.1 | 17.1 | 8.7 | 0.1 | 0.2 |
| Short Term Investments | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0.4 | 0.3 | 17.8 K | 44.2 K | 40.8 K |
| Inventory | 0.6 | 0.2 | (863.1) | 0 | 0 |
| Other Current Assets | 0.9 | 0.8 | 0.9 | 21 K | 15.6 K |
| Total Current Assets | 9.0 | 18.4 | 9.6 | 0.2 | 0.3 |
| PP&E | 3.0 | 1.8 | 0.4 | 0.5 | 0.5 |
| Intangible Assets | 3.4 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 108 | 23.3 K | (0.4) | (0.5) | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 15.4 | 20.2 | 10.0 | 0.7 | 0.7 |
| LIABILITIES | |||||
| Accounts Payable | 2.3 | 1.3 | 0.8 | 0.2 | 0.2 |
| Short Term Debt | 5.2 | 1.3 | 0.2 | 0.1 | 0.2 |
| Other Current Liabilities | 1.5 | 1.6 | 0.3 | 0.4 | 44.4 K |
| Total Current Liabilities | 9.2 | 4.2 | 1.4 | 0.7 | 0.5 |
| Long Term Debt | 2.2 | 1.9 | 2.3 | 2.7 | 2.2 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0.7 | 0 | 0 | 0 | 0 |
| Total Liabilities | 12.2 | 6.1 | 3.7 | 3.4 | 2.7 |
| EQUITY | |||||
| Common Stock | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 |
| Retained Earnings | (69.3) | (43.0) | (16.6) | (5.0) | (4.4) |
| Other Accumulative Comprehensive Income/Loss | 20.8 | 18.1 | 9.7 | 2.1 | 2.3 |
| Total Equity | 3.2 | 14.1 | 6.4 | (2.7) | (2.0) |
| Total Liabilities and Equity | 15.4 | 20.2 | 10.0 | 0.7 | 0.7 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 16.2 | 14.2 | 7.2 | 5.6 | 11.7 |